SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, +256

Nature

SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp, Dami A. Collier, Rawlings Datir, +10

Nature

Viral PersistenceViral PathogenesisVirologyMedicineChronic Infection +2

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Dami A. Collier, Isabella A.T.M. Ferreira, Prasanti Kotagiri, +5

Nature

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, +18

Nature

VaccinationVaccine DevelopmentImmunologyVirologySars-cov-2 B.1.1.7 +2

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng, Steven A. Kemp, Guido Papa, +869

Cell Reports

Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70

Steven A. Kemp, Bo Meng, Isabella ATM Ferriera, +21

Viral PathogenesisImmunologyImmunodominanceViral Structural ProteinVirus Transmission +14

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation

Dami A. Collier, Rawlings Datir, IATM Ferreira, +26

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion

Isabella A.T.M. Ferreira, Steven A. Kemp, Rawlings Datir, +14

The Journal of Infectious Diseases

VaccinationVaccine DevelopmentAntibody EvasionImmunologyLate 2020 +13

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, +36

Recurrent Emergence and Transmission of a SARS-CoV-2 Spike Deletion H69/V70

Steven A. Kemp, Isabella ATM Ferriera, Rawlings Datir, +4

SSRN Electronic Journal